The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Clinical pharmacokinetics; concepts and applications
(1989) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(89)90348-0 · Cited by 2,223
Structural Basis of the Drug-binding Specificity of Human Serum Albumin
Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., & Curry, S. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.075 · Cited by 1,941
A physiological approach to hepatic drug clearance
Wilkinson, G. R., & Shand, D. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975184377 · Cited by 1,873
POOR NUTRITIONAL STATUS AND INFLAMMATION: Serum Albumin: Relationship to Inflammation and Nutrition
Don, B. R., & Kaysen, G. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17603.x · Cited by 1,410
Schinkel, A. H., Wagenaar, E., Mol, C. A., & van Deemter, L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118699 · Cited by 1,264
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Changes in plasma protein binding have little clinical relevance
Benet, L. Z., & Hoener, B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121829 · Cited by 825
Clearance concepts in pharmacokinetics
Rowland, M., Benet, L. Z., & Graham, G. G. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059626 · Cited by 649
Drug binding to human alpha-1-acid glycoprotein in health and disease.
Kremer, J. M., Wilting, J., & Janssen, L. H. (1988) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00015-8 · Cited by 583
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H., & Drusano, G. L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki079 · Cited by 549
Self-citationTransporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties
Hochepied, T., Berger, F. G., Baumann, H., & Libert, C. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00054-0 · Cited by 457
Increased drug delivery to the brain by P-glycoprotein inhibition
Sadeque, A. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109156 · Cited by 426
Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes
Rodgers, T., & Rowland, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9210-3 · Cited by 420
HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
Israili, Z. H., & Dayton, P. G. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100104402 · Cited by 367
Disease-induced Changes in the Plasma Binding of Basic Drugs
Piafsky, K. M. (1980) · Clinical Pharmacokinetics · doi:10.2165/00003088-198005030-00004 · Cited by 358
Bertucci, C., & Domenici, E. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023369673 · Cited by 354
FACTORS AFFECTING DRUG METABOLISM
Gillette, J. R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46890.x · Cited by 348
Craig, W. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321854 · Cited by 318
Berezhkovskiy, L. M. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20073 · Cited by 296
Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution
Øie, S., & Tozer, T. N. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600680948 · Cited by 256
Red Blood Cells: A Neglected Compartment in Pharmacokinetics and Pharmacodynamics
Hinderling, P. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01329-2 · Cited by 250
Clinical Pharmacokinetics: Concepts and Applications
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-6-500_4 · Cited by 247
A Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
Otagiri, M. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.309 · Cited by 228
The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients
Joynt, G. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.421 · Cited by 200
Plasma Drug Binding: Implications for Anesthesiologists
Wood, M. (1986) · Anesthesia & Analgesia · doi:10.1213/00000539-198607000-00015 · Cited by 163
Kalvass, J. C., Olson, E. R., Cassidy, M. P., Selley, D. E., & Pollack, G. M. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119560 · Cited by 161
Lombardo, F., Obach, R. S., Shalaeva, M. Y., & Gao, F. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030408h · Cited by 159
Silvasti, M., Rosenberg, P. H., Seppälä, T. T., Svartling, N. E., & Pitkanen, M. T. (1998) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1998.tb05169.x · Cited by 157
Protein Binding of Antimicrobials
Craig, W. A., & Welling, P. G. (1977) · Clinical Pharmacokinetics · doi:10.2165/00003088-197702040-00002 · Cited by 156
Plasma drug binding: implications for anesthesiologists.
Wood, M. (1986) · PubMed · Cited by 153
INFLUENCE OF BINDING ON THE PHARMACOLOGIC ACTIVITY OF ANTIBIOTICS
Kunin, C. M., Craig, W. A., Kornguth, M. L., & Monson, R. A. (1973) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1973.tb20483.x · Cited by 146
Heel, R. C., Brogden, R. N., Speight, T. M., & Avery, G. S. (1978) · Drugs · doi:10.2165/00003495-197815010-00003 · Cited by 140
Kunin, C. M. (1966) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196672166 · Cited by 138
Free drug fraction vs. free drug concentration: a matter of frequent confusion
Toutain, P., & Bousquet‐mélou, A. (2002) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1046/j.1365-2885.2002.00442.x · Cited by 133
Tj, U., Brown, C., Castro, R. A., Shah, N. D., Mercer, R., Huang, Y. L., Brett, C., Burchard, E. G., & Giacomini, K. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100271 · Cited by 133
Boström, E., Hammarlund‐Udenaes, M., & Simonsson, U. S. H. (2008) · Anesthesiology · doi:10.1097/aln.0b013e318164cf9e · Cited by 122
How the Lung Handles Drugs: Pharmacokinetics and Pharmacodynamics of Inhaled Corticosteroids
Winkler, J., Hochhaus, G., & Derendorf, H. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200403-025ms · Cited by 122
Self-citationPoulin, P., & Theil, F. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21759 · Cited by 120
Lipworth, B. J., Kaliner, M., LaForce, C., Baker, J., Kaiser, H. B., Amin, D., Kundu, S., WILLIAMS, J. E. J., Engelstätter, R., & Banerji, D. D. (2005) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61117-9 · Cited by 116
Mandema, J. W., Sansom, L. N., Dios-Viéitez, M. D. C., Hollander-Jansen, M., & Danhof, M. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24740-1 · Cited by 115
Effect of Protein Binding on the Pharmacological Activity of Highly Bound Antibiotics
Schmidt, S., Röck, K., Sahre, M. D., Burkhardt, O., Brunner, M., Lobmeyer, M. T., & Derendorf, H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00427-08 · Cited by 113
Self-citationConcepts basic to pharmacokinetics
Tozer, T. N. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90077-2 · Cited by 111
Brown, R. P. A., Aplin, R. T., & Schofield, C. J. (1996) · Biochemistry · doi:10.1021/bi961044g · Cited by 111
Gieschke, R., Fotteler, B., Buss, N., & Steimer, J. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937010-00005 · Cited by 97
Hypoalbuminemia in Renal Failure: Pathogenesis and Therapeutic Considerations
Haller, C. (2005) · Kidney & Blood Pressure Research · doi:10.1159/000090185 · Cited by 96
Structure of human -acid glycoprotein and its high-affinity binding site
Kopecký, V., Ettrich, R. H., Hofbauerová, K., & Baumruk, V. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02765-1 · Cited by 88
Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: An overview
Dingemanse, J., Danhof, M., & Breimer, D. D. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90101-5 · Cited by 83
Rohatagi, S., Luo, Y., Shen, L., Guo, Z., Schemm, C., Huang, Y., Chen, K. S., David, M., Nave, R., & King, S. P. (2005) · PubMed · Cited by 78
Curtis, G. B., Johnson, G. H., Clark, P., Taylor, R., Brown, J. D., O’Callaghan, R., Shi, M., & Lacouture, P. G. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050651 · Cited by 78
Lee, D. K. C., Fardon, T. C., Bates, C. E., Haggart, K., McFarlane, L. C., & Lipworth, B. J. (2005) · CHEST Journal · doi:10.1378/chest.127.3.851 · Cited by 77
Beer, J., Wagner, C. C., & Zeitlinger, M. A. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9072-1 · Cited by 74
Cloyd, J. C., Dutta, S., Cao, G., Walch, J. K., Collins, S. D., & Granneman, G. R. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00251-6 · Cited by 64
Estimating the contribution of genes and environment to variation in renal drug clearance
Leabman, M. K., & Giacomini, K. M. (2003) · Pharmacogenetics · doi:10.1097/00008571-200309000-00007 · Cited by 62
Kaliner, M. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.03.003 · Cited by 47
Cha, R., & Rybak, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh259 · Cited by 47
Decreased protein binding and thiopental kinetics
Burch, P. G., & Stanski, D. R. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.150 · Cited by 46
Rohatagi, S., Krishnaswami, S., Pfister, M., & Sahasranaman, S. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000155110.69831.75 · Cited by 44
Cafini, F., Aguilar, L., González, N., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm078 · Cited by 43
Jackson, A. J. (1994) · Cited by 39
Role of Protein Binding in Pharmacokinetics
Mehvar, R. (2005) · American Journal of Pharmaceutical Education · doi:10.5688/aj69051526 · Cited by 34
Comparison between Narcotic “Receptors” in the Guinea‐pig Ileum and the Rat Brain
Terenius, L. Y. (1975) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1975.tb00837.x · Cited by 32
Elements of design: the knowledge on which we build
MacGowan, A. P. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00863.x · Cited by 31
Effect of Oral Ketoconazole on First‐pass Effect of Nifedipine After Oral Administration in Dogs
Kuroha, M., Kayaba, H., Kishimoto, S., Khalil, W. F., Shimoda, M., & KOKUE, E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10086 · Cited by 27
Marathe, A., Krzyżański, W., & Mager, D. E. (2009) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-009-9118-8 · Cited by 27
On the prediction of hepatic clearance using the diluted plasma in metabolic stability assay
Berezhkovskiy, L. M., Khojasteh, S. C., Halladay, J. S., & Hop, C. E. C. A. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21582 · Cited by 21
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery
Smith, D. A., Di, L., & Kerns, E. H. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3287 · Cited by 898
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809
Tsai, Y.-M., Chien, C.-F., Lin, L.-C., & Tsai, T.-H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.030 · Cited by 535
Metadata
- Authors
- Schmidt, S., Gonzalez, D., & Derendorf, H.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 99
- Issue
- 3
- Pages
- 1107-1122
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2168276530
- Cited by
- 335
- References
- 68
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.